Top
Skip to Content
LOGO(small) - Queen's University Belfast
  • Our twitter
  • Our
  • Our
  • Our
LOGO(large) - Queen's University Belfast

Centre for Public Health

  • Home
  • About
    • About Us
    • Education
    • Find a PhD Supervisor
    • Nursing Mothers' Rooms and Breastfeeding Facilities
  • Research
    • Cancer Epidemiology
    • Epidemiology & Public Health
    • Health Services & Global Health
    • Public Health Nutrition
  • Events
  • News
  • Contact Us
    • Staff
  • Showcasing our research
  • Related Links
  • Home
  • About
    • About Us
    • Education
    • Find a PhD Supervisor
    • Nursing Mothers' Rooms and Breastfeeding Facilities
  • Research
    • Cancer Epidemiology
    • Epidemiology & Public Health
    • Health Services & Global Health
    • Public Health Nutrition
  • Events
  • News
  • Contact Us
    • Staff
  • Showcasing our research
  • Related Links
  • Our twitter
  • Our
  • Our
In This Section

  • Home
  • Centre for Public Health
  • News

News

Centre for Public Health researcher awarded prestigious Future Leader Fellowships by UKRI

23 April, 2020

Dr. Úna McMenamin has been awarded Future Leaders Fellowships as part of a new investment announced today by UK Research and Innovation (UKRI).

Dr Úna McMenamin from the Centre for Public Health, received an award of over £883,000 to develop one of the first population-based registers for the precursor condition of the most commonly diagnosed gynaecological cancer. The research will use routinely collected health records to improve diagnostics and treatment while leading to improved clinical guidelines on a global scale.

Dr Úna McMenamin
Dr Úna McMenamin

Endometrial cancer, also referred to as womb cancer, is the most commonly diagnosed gynaecological cancer in the UK and is rapidly rising in incidence, especially in younger women. There is no routine screening for endometrial cancer and primary treatment involves a hysterectomy, meaning a woman is forced to lose her fertility if treatment is required. Endometrial hyperplasia is a recognised precursor, which if detected, can help to prevent the disease progressing to endometrial cancer.

Dr. McMenamin, whose research will provide the first population-based endometrial hyperplasia register in Europe, explains: “The current lack of data and information around this common cancer is alarming. I am delighted to have the opportunity to address this through establishing a register in Northern Ireland that will enable novel data linkages to important clinical datasets allowing us to identify the women most at risk of progression to endometrial cancer. The register will be facilitated by the Northern Ireland Cancer Registry, which is funded by the Northern Ireland Public Health Agency.

“This research programme will generate robust population-level evidence to inform diagnostic, treatment and surveillance guidelines for women with endometrial hyperplasia and endometrial cancer and will ultimately lead to better informed clinical decision-making between women and their health care professionals.”

Share
Latest News
  • Queen’s University Belfast to drive forward vital study into secondary breast cancer
    28 February, 2023
  • Patrick G Johnson Centre for Cancer Research Public Open Day
    27 February, 2023
  • Summer Studentships 2023
    27 February, 2023
  • PhD Opportunities available
    18 December, 2022
  • Call for Abstracts: North South Public Health Conference – Healthy Planet, Healthy People
    19 July, 2022
Home
  • Home
  • About
  • Research
  • Events
  • News
  • Contact Us
  • Showcasing our research
  • Related Links
Queen's University Belfast - Logo (small)
Contact Us

Centre for Public Health
Institute of Clinical Sciences
Royal Victoria Hospital
Belfast
BT12 6BA

Phone: +44 (0) 28 9097 6350

Quick Links

  • Home
  • Research
  • About

 

© Queen's University Belfast 2023
Privacy and cookies
Website accessibility
Freedom of information
Modern slavery statement
Equality, Diversity and Inclusion
Manage cookies